AAAAAA
Results: 1-25/1748
Authors:
Redington, AE
Citation: Ae. Redington, Step one for asthma treatment - beta(2)-agonists or inhaled corticosteroids?, DRUGS, 61(9), 2001, pp. 1231-1238
Authors:
Li, YY
Feldman, AM
Citation: Yy. Li et Am. Feldman, Matrix metalloproteinases in the progression of heart failure - Potential therapeutic implications, DRUGS, 61(9), 2001, pp. 1239-1252
Authors:
McCloskey, EV
Guest, JF
Kanis, JA
Citation: Ev. Mccloskey et al., The clinical and cost considerations of bisphosphonates in preventing bonecomplications in patients with metastatic breast cancer or multiple myeloma, DRUGS, 61(9), 2001, pp. 1253-1274
Authors:
Biering-Sorensen, F
Bagi, P
Hoiby, N
Citation: F. Biering-sorensen et al., Urinary tract infections in patients with spinal cord lesions - Treatment and prevention, DRUGS, 61(9), 2001, pp. 1275-1287
Authors:
Comino, E
Henry, R
Citation: E. Comino et R. Henry, Changing approaches to asthma management in Australia - Effects on asthma morbidity, DRUGS, 61(9), 2001, pp. 1289-1300
Authors:
Kersten, MJ
Van Oers, RHJ
Citation: Mj. Kersten et Rhj. Van Oers, Management of AIDS-Related non-Hodgkin's lymphomas, DRUGS, 61(9), 2001, pp. 1301-1315
Authors:
McGavin, JK
Spencer, CM
Citation: Jk. Mcgavin et Cm. Spencer, Gemtuzumab ozogamicin, DRUGS, 61(9), 2001, pp. 1317-1322
Authors:
Appelbaum, FR
Citation: Fr. Appelbaum, Gemtuzumab ozogamicin - Viewpoint, DRUGS, 61(9), 2001, pp. 1323-1323
Authors:
Burnett, AK
Citation: Ak. Burnett, Gemtuzumab ozogamicin - Viewpoint, DRUGS, 61(9), 2001, pp. 1323-1324
Authors:
Grossbard, ML
Citation: Ml. Grossbard, Gemtuzumab ozogamicin - Viewpoint, DRUGS, 61(9), 2001, pp. 1324-1324
Authors:
Sharpe, M
Jarvis, B
Citation: M. Sharpe et B. Jarvis, Inhaled mometasone furoate - A review of its use in adults and adolescentswith persistent asthma, DRUGS, 61(9), 2001, pp. 1325-1350
Authors:
Dooley, M
Spencer, CM
Dunn, CJ
Citation: M. Dooley et al., Aceclofenac - A reappraisal of its use in the management of pain and rheumatic disease, DRUGS, 61(9), 2001, pp. 1351-1378
Authors:
Zellweger, JP
Citation: Jp. Zellweger, Anti-smoking therapies - Is harm reduction a viable alternative to smokingcessation?, DRUGS, 61(8), 2001, pp. 1041-1044
Authors:
Temkin, NR
Jarell, AD
Anderson, GD
Citation: Nr. Temkin et al., Antiepileptogenic agents - How close are we?, DRUGS, 61(8), 2001, pp. 1045-1055
Authors:
Markman, M
Citation: M. Markman, Intraperitoneal drug delivery of antineoplastics, DRUGS, 61(8), 2001, pp. 1057-1065
Authors:
Roos, TC
Alam, M
Roos, S
Merk, HF
Bickers, DR
Citation: Tc. Roos et al., Pharmacotherapy of ectoparasitic infections, DRUGS, 61(8), 2001, pp. 1067-1088
Authors:
Hung, TV
Bounaix, MJ
Fraysse, B
Citation: Tv. Hung et al., Meniere's disease - Pathophysiology and treatment, DRUGS, 61(8), 2001, pp. 1089-1102
Authors:
Gibbs, DD
Gore, ME
Citation: Dd. Gibbs et Me. Gore, Pursuit of optimum outcomes in ovarian cancer - Methodological approaches to therapy, DRUGS, 61(8), 2001, pp. 1103-1120
Authors:
Keating, GM
Jarvis, B
Citation: Gm. Keating et B. Jarvis, Caspofungin, DRUGS, 61(8), 2001, pp. 1121-1129
Authors:
De Pauw, BE
Citation: Be. De Pauw, Caspofungin - A viewpoint by Ben E. De Pauw, DRUGS, 61(8), 2001, pp. 1130-1130
Authors:
Leather, H
Wingard, J
Citation: H. Leather et J. Wingard, Caspofungin - A viewpoint by Helen Leather and John Wingard, DRUGS, 61(8), 2001, pp. 1131-1131
Authors:
Cheer, SM
Goa, KL
Citation: Sm. Cheer et Kl. Goa, Parecoxib (parecoxib sodium), DRUGS, 61(8), 2001, pp. 1133-1141
Authors:
Huskisson, EC
Citation: Ec. Huskisson, Parecoxib - A viewpoint by Edward C. Huskisson, DRUGS, 61(8), 2001, pp. 1142-1143
Authors:
Carr, D
Citation: D. Carr, Parecoxib - A viewpoint by Daniel Carr, DRUGS, 61(8), 2001, pp. 1142-1142
Authors:
Curran, M
Noble, S
Citation: M. Curran et S. Noble, Valganciclovir, DRUGS, 61(8), 2001, pp. 1145-1150